Belma, Baby Girl -.

HRN: 26 10 02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2024
AMPICILLIN 250MG (VIAL)
10/23/2024
10/30/2024
IV
250mg
Q12H
PCAP C
Waiting Final Action 
10/23/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/23/2024
10/30/2024
IV
75mg
Q24H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: